

4-AA, CAS number: 76855-69-1, chemical name: (3S,4R)-4-Acetoxy-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]azetidin-2-one. It is a key intermediate for the synthesis of penem drugs.
The global 4-AA API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for 4-AA API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for 4-AA API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of 4-AA API include Zhejiang Hisoar Pharmaceutical, Zhejiang Jiuzhou Pharmaceutical, Jiangxi Fushine Pharmaceutical, Sichuan Xindi Pharmaceutical, Shandong Jincheng Pharmaceutical, Xinxiang Haibin Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for 4-AA API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 4-AA API.
The 4-AA API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global 4-AA API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 4-AA API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Zhejiang Hisoar Pharmaceutical
Zhejiang Jiuzhou Pharmaceutical
Jiangxi Fushine Pharmaceutical
Sichuan Xindi Pharmaceutical
Shandong Jincheng Pharmaceutical
Xinxiang Haibin Pharmaceutical
Segment by Type
99% Purity
99.5% Purity
Segment by Application
Meropenem
Imipenem
Biapenem
Ertapenem
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of 4-AA API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of 4-AA API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 4-AA API Market Overview
1.1 Product Definition
1.2 4-AA API by Type
1.2.1 Global 4-AA API Market Value Comparison by Type (2024-2030)
1.2.2 99% Purity
1.2.3 99.5% Purity
1.3 4-AA API by Application
1.3.1 Global 4-AA API Market Value by Application (2024-2030)
1.3.2 Meropenem
1.3.3 Imipenem
1.3.4 Biapenem
1.3.5 Ertapenem
1.3.6 Others
1.4 Global 4-AA API Market Size Estimates and Forecasts
1.4.1 Global 4-AA API Revenue 2019-2030
1.4.2 Global 4-AA API Sales 2019-2030
1.4.3 Global 4-AA API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 4-AA API Market Competition by Manufacturers
2.1 Global 4-AA API Sales Market Share by Manufacturers (2019-2024)
2.2 Global 4-AA API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global 4-AA API Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of 4-AA API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of 4-AA API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 4-AA API, Product Type & Application
2.7 Global Key Manufacturers of 4-AA API, Date of Enter into This Industry
2.8 Global 4-AA API Market Competitive Situation and Trends
2.8.1 Global 4-AA API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest 4-AA API Players Market Share by Revenue
2.8.3 Global 4-AA API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global 4-AA API Market Scenario by Region
3.1 Global 4-AA API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global 4-AA API Sales by Region: 2019-2030
3.2.1 Global 4-AA API Sales by Region: 2019-2024
3.2.2 Global 4-AA API Sales by Region: 2025-2030
3.3 Global 4-AA API Revenue by Region: 2019-2030
3.3.1 Global 4-AA API Revenue by Region: 2019-2024
3.3.2 Global 4-AA API Revenue by Region: 2025-2030
3.4 North America 4-AA API Market Facts & Figures by Country
3.4.1 North America 4-AA API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America 4-AA API Sales by Country (2019-2030)
3.4.3 North America 4-AA API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe 4-AA API Market Facts & Figures by Country
3.5.1 Europe 4-AA API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe 4-AA API Sales by Country (2019-2030)
3.5.3 Europe 4-AA API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 4-AA API Market Facts & Figures by Region
3.6.1 Asia Pacific 4-AA API Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific 4-AA API Sales by Region (2019-2030)
3.6.3 Asia Pacific 4-AA API Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America 4-AA API Market Facts & Figures by Country
3.7.1 Latin America 4-AA API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America 4-AA API Sales by Country (2019-2030)
3.7.3 Latin America 4-AA API Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa 4-AA API Market Facts & Figures by Country
3.8.1 Middle East and Africa 4-AA API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa 4-AA API Sales by Country (2019-2030)
3.8.3 Middle East and Africa 4-AA API Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 4-AA API Sales by Type (2019-2030)
4.1.1 Global 4-AA API Sales by Type (2019-2024)
4.1.2 Global 4-AA API Sales by Type (2025-2030)
4.1.3 Global 4-AA API Sales Market Share by Type (2019-2030)
4.2 Global 4-AA API Revenue by Type (2019-2030)
4.2.1 Global 4-AA API Revenue by Type (2019-2024)
4.2.2 Global 4-AA API Revenue by Type (2025-2030)
4.2.3 Global 4-AA API Revenue Market Share by Type (2019-2030)
4.3 Global 4-AA API Price by Type (2019-2030)
5 Segment by Application
5.1 Global 4-AA API Sales by Application (2019-2030)
5.1.1 Global 4-AA API Sales by Application (2019-2024)
5.1.2 Global 4-AA API Sales by Application (2025-2030)
5.1.3 Global 4-AA API Sales Market Share by Application (2019-2030)
5.2 Global 4-AA API Revenue by Application (2019-2030)
5.2.1 Global 4-AA API Revenue by Application (2019-2024)
5.2.2 Global 4-AA API Revenue by Application (2025-2030)
5.2.3 Global 4-AA API Revenue Market Share by Application (2019-2030)
5.3 Global 4-AA API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zhejiang Hisoar Pharmaceutical
6.1.1 Zhejiang Hisoar Pharmaceutical Company Information
6.1.2 Zhejiang Hisoar Pharmaceutical Description and Business Overview
6.1.3 Zhejiang Hisoar Pharmaceutical 4-AA API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zhejiang Hisoar Pharmaceutical 4-AA API Product Portfolio
6.1.5 Zhejiang Hisoar Pharmaceutical Recent Developments/Updates
6.2 Zhejiang Jiuzhou Pharmaceutical
6.2.1 Zhejiang Jiuzhou Pharmaceutical Company Information
6.2.2 Zhejiang Jiuzhou Pharmaceutical Description and Business Overview
6.2.3 Zhejiang Jiuzhou Pharmaceutical 4-AA API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zhejiang Jiuzhou Pharmaceutical 4-AA API Product Portfolio
6.2.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
6.3 Jiangxi Fushine Pharmaceutical
6.3.1 Jiangxi Fushine Pharmaceutical Company Information
6.3.2 Jiangxi Fushine Pharmaceutical Description and Business Overview
6.3.3 Jiangxi Fushine Pharmaceutical 4-AA API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jiangxi Fushine Pharmaceutical 4-AA API Product Portfolio
6.3.5 Jiangxi Fushine Pharmaceutical Recent Developments/Updates
6.4 Sichuan Xindi Pharmaceutical
6.4.1 Sichuan Xindi Pharmaceutical Company Information
6.4.2 Sichuan Xindi Pharmaceutical Description and Business Overview
6.4.3 Sichuan Xindi Pharmaceutical 4-AA API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sichuan Xindi Pharmaceutical 4-AA API Product Portfolio
6.4.5 Sichuan Xindi Pharmaceutical Recent Developments/Updates
6.5 Shandong Jincheng Pharmaceutical
6.5.1 Shandong Jincheng Pharmaceutical Company Information
6.5.2 Shandong Jincheng Pharmaceutical Description and Business Overview
6.5.3 Shandong Jincheng Pharmaceutical 4-AA API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shandong Jincheng Pharmaceutical 4-AA API Product Portfolio
6.5.5 Shandong Jincheng Pharmaceutical Recent Developments/Updates
6.6 Xinxiang Haibin Pharmaceutical
6.6.1 Xinxiang Haibin Pharmaceutical Company Information
6.6.2 Xinxiang Haibin Pharmaceutical Description and Business Overview
6.6.3 Xinxiang Haibin Pharmaceutical 4-AA API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Xinxiang Haibin Pharmaceutical 4-AA API Product Portfolio
6.6.5 Xinxiang Haibin Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 4-AA API Industry Chain Analysis
7.2 4-AA API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 4-AA API Production Mode & Process
7.4 4-AA API Sales and Marketing
7.4.1 4-AA API Sales Channels
7.4.2 4-AA API Distributors
7.5 4-AA API Customers
8 4-AA API Market Dynamics
8.1 4-AA API Industry Trends
8.2 4-AA API Market Drivers
8.3 4-AA API Market Challenges
8.4 4-AA API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Zhejiang Hisoar Pharmaceutical
Zhejiang Jiuzhou Pharmaceutical
Jiangxi Fushine Pharmaceutical
Sichuan Xindi Pharmaceutical
Shandong Jincheng Pharmaceutical
Xinxiang Haibin Pharmaceutical
Ìý
Ìý
*If Applicable.